US Government Poised for Long-Awaited Powers on Drug Pricing

August 9, 2022

Pharma rarely loses in Washington. For years, the industry has successfully defeated US government efforts to rein in drug pricing, arguing any such moves would prevent companies from developing newer and better medicines. That argument doesn’t seem to be enough anymore. Read More

Past Reports